Back to Selection     Print       Date : 31 Oct 2025
Fund Summary
Tata India Pharma & HealthCare Fund Reg Plan (G)
[Equity: Sectoral]  
 
Fund Details
Fund Type Growth Launch Date 28-Dec-15
Corpus(Cr.) 1325.0 Latest NAV 30.6771 As on 05-12-2025
Equity(%) 98.47 52 Week High 32.0131
Debt(%) 1.53 52 Week Low 26.5729
Others(%) 0.0 Exit Load 0.25% for redemption within 30 days
Minimum Investment - Availability
Entry Load Nil Expense Ratio(%) 2.10
Scheme Benchmark BSE Healthcare TRI Broader Benchmark NSE - Nifty 50 TRI
Fund Manager Rajat Srivastava
 
Riskometer
Investors understand that their principal will be at Very High risk
 
Scheme Objective
The scheme seeks long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.

Portfolio Classification
 
Asset Mix
 
Concentration Analysis
Top 5 Holdings 29.29%
Top 10 Holdings 49.73%
Top 25 Holdings 90.31%
 
Sector Analysis
Sector/Ratings Net Asset(%)
Pharma & Biotech 61.21
Healthcare 35.09
Fertilisers 2.17
Cash 1.53
 
 
 
 
 
Portfolio Metrics
PB Ratio 6.60
PE Ratio 44.66
 
Top 25 Holdings
Holdings Net Asset(%)
Sun Pharmaceutical Industries Limited 9.59
Apollo Hospitals Enterprise Limited 5.13
Healthcare Global Enterprises Limited 4.96
Lupin Limited 4.90
Max Healthcare Institute Limited 4.71
Torrent Pharmaceuticals Limited 4.52
Alkem Laboratories Limited 4.42
Abbott India Limited 4.02
Cipla Limited 3.92
IPCA Laboratories Limited 3.56
Ajanta Pharma Limited 3.35
Rainbow Childrens Medicare Limited 3.30
Aster DM Healthcare Limited 3.29
DIVI LABORATORIES LTD 3.26
J B Chemicals and Pharma Ltd 3.22
Metropolis Healthcare Limited 3.18
FDC Limited 2.93
Dr Lal Path Labs Ltd 2.89
Mankind Pharma Limited 2.63
Dr Agarwals Health Care Limited 2.33
P I Industries Ltd 2.17
Glenmark Pharmaceuticals Limited 2.17
Sai Life Sciences Limited 2.09
Krishna Inst of Medical Sciences Ltd. 2.01
Syngene International Limited 1.76

Performance Analysis
 
Short Terms Returns
1 Month 3 Month 6 Month 1 Year
-0.29% -0.30% 3.81% -0.43%
 
Broader Market Benchmark [NSE - Nifty 50 TRI]
2.70% 6.00% 5.46% 7.43%
 
Scheme Benchmark [NSE - Nifty Pharma]
3.13% 4.66% 5.82% 2.28%
 
Long term Returns
2 Year 3 Year 5 Year 10 Year
18.77% 21.67% 16.15% 0.00%
 
 
13.19% 13.29% 15.94% 14.28%
 
 
19.13% 20.99% 13.17% 7.01%
 
Cumulative Performance of Last 5 Years
 
Calendar Year Returns

Risk Analysis
 
Absolute Metrics (Single Computation - last 3 years)
Scheme Name Standard Deviation Sharpe Ratio Downside Deviation Downside Probability Sortino Ratio
Tata India Pharma & HealthCare Fund Reg Plan (G) 16.04% 1.0041 10.4933% 44.9256 0.1436
 
Benchmark Relative Metrics (Single Computation - last 3 years)
Scheme Name Alpha Beta Treynor Ratio Tracking Error Information Ratio
Tata India Pharma & HealthCare Fund Reg Plan (G) 11.5698% 0.0002 0.2775 14.5650 0.7388
 
Back to Selection